United States Microbiome Therapeutics Market Report 2018

March 2018 | 115 pages | ID: U9F527A9EB8EN
QYResearch

Abstracts

In this report, the United States Microbiome Therapeutics market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Microbiome Therapeutics in these regions, from 2013 to 2025 (forecast).

United States Microbiome Therapeutics market competition by top manufacturers/players, with Microbiome Therapeutics sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Seres Therapeutics
• Assembly Biosciences
• Synthetic Biologics
• Interxon
• PureTech
• Synlogic
• Enterome BioScience
• 4D Pharma
• Second Genome
• AOBiome
• C3 Jian
• Rebiotix
• MicroBiome Therapeutics LLC
• Metabiomics
• Ritter Pharmaceuticals
• Symberix
• OpenBiome
• Azitra
• Symbiotix Biotherapies
• Osel
• Metabogen

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Probiotic Type
• Fructo-Oligosaccharides
• Galacto-Oligosaccharides
• Inulin

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• C. difficile Infection (CDI)
• Inflammatory Bowel Disease (IBD)
• Orphan Drug
• Immuno-oncology
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Microbiome Therapeutics Market Report 2018

1 MICROBIOME THERAPEUTICS OVERVIEW

1.1 Product Overview and Scope of Microbiome Therapeutics
1.2 Classification of Microbiome Therapeutics by Product Category
  1.2.1 United States Microbiome Therapeutics Market Size (Sales Volume) Comparison by Type (2013-2025)
  1.2.2 United States Microbiome Therapeutics Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
  1.2.3 Probiotic Type
  1.2.4 Fructo-Oligosaccharides
  1.2.5 Galacto-Oligosaccharides
  1.2.6 Inulin
1.3 United States Microbiome Therapeutics Market by Application/End Users
  1.3.1 United States Microbiome Therapeutics Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
  1.3.2 C. difficile Infection (CDI)
  1.3.3 Inflammatory Bowel Disease (IBD)
  1.3.4 Orphan Drug
  1.3.5 Immuno-oncology
  1.3.6 Others
1.4 United States Microbiome Therapeutics Market by Region
  1.4.1 United States Microbiome Therapeutics Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 The West Microbiome Therapeutics Status and Prospect (2013-2025)
  1.4.3 Southwest Microbiome Therapeutics Status and Prospect (2013-2025)
  1.4.4 The Middle Atlantic Microbiome Therapeutics Status and Prospect (2013-2025)
  1.4.5 New England Microbiome Therapeutics Status and Prospect (2013-2025)
  1.4.6 The South Microbiome Therapeutics Status and Prospect (2013-2025)
  1.4.7 The Midwest Microbiome Therapeutics Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Microbiome Therapeutics (2013-2025)
  1.5.1 United States Microbiome Therapeutics Sales and Growth Rate (2013-2025)
  1.5.2 United States Microbiome Therapeutics Revenue and Growth Rate (2013-2025)

2 UNITED STATES MICROBIOME THERAPEUTICS MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Microbiome Therapeutics Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Microbiome Therapeutics Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Microbiome Therapeutics Average Price by Players/Suppliers (2013-2018)
2.4 United States Microbiome Therapeutics Market Competitive Situation and Trends
  2.4.1 United States Microbiome Therapeutics Market Concentration Rate
  2.4.2 United States Microbiome Therapeutics Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Microbiome Therapeutics Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES MICROBIOME THERAPEUTICS SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2013-2018)

3.1 United States Microbiome Therapeutics Sales and Market Share by Region (2013-2018)
3.2 United States Microbiome Therapeutics Revenue and Market Share by Region (2013-2018)
3.3 United States Microbiome Therapeutics Price by Region (2013-2018)

4 UNITED STATES MICROBIOME THERAPEUTICS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2013-2018)

4.1 United States Microbiome Therapeutics Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Microbiome Therapeutics Revenue and Market Share by Type (2013-2018)
4.3 United States Microbiome Therapeutics Price by Type (2013-2018)
4.4 United States Microbiome Therapeutics Sales Growth Rate by Type (2013-2018)

5 UNITED STATES MICROBIOME THERAPEUTICS SALES (VOLUME) BY APPLICATION (2013-2018)

5.1 United States Microbiome Therapeutics Sales and Market Share by Application (2013-2018)
5.2 United States Microbiome Therapeutics Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 UNITED STATES MICROBIOME THERAPEUTICS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Seres Therapeutics
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Microbiome Therapeutics Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Seres Therapeutics Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Assembly Biosciences
  6.2.2 Microbiome Therapeutics Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Assembly Biosciences Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 Synthetic Biologics
  6.3.2 Microbiome Therapeutics Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Synthetic Biologics Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 Interxon
  6.4.2 Microbiome Therapeutics Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Interxon Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 PureTech
  6.5.2 Microbiome Therapeutics Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 PureTech Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview
6.6 Synlogic
  6.6.2 Microbiome Therapeutics Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Synlogic Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2013-2018)
  6.6.4 Main Business/Business Overview
6.7 Enterome BioScience
  6.7.2 Microbiome Therapeutics Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Enterome BioScience Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2013-2018)
  6.7.4 Main Business/Business Overview
6.8 4D Pharma
  6.8.2 Microbiome Therapeutics Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 4D Pharma Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2013-2018)
  6.8.4 Main Business/Business Overview
6.9 Second Genome
  6.9.2 Microbiome Therapeutics Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Second Genome Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2013-2018)
  6.9.4 Main Business/Business Overview
6.10 AOBiome
  6.10.2 Microbiome Therapeutics Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 AOBiome Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2013-2018)
  6.10.4 Main Business/Business Overview
6.11 C3 Jian
6.12 Rebiotix
6.13 MicroBiome Therapeutics LLC
6.14 Metabiomics
6.15 Ritter Pharmaceuticals
6.16 Symberix
6.17 OpenBiome
6.18 Azitra
6.19 Symbiotix Biotherapies
6.20 Osel
6.21 Metabogen

7 MICROBIOME THERAPEUTICS MANUFACTURING COST ANALYSIS

7.1 Microbiome Therapeutics Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Microbiome Therapeutics

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Microbiome Therapeutics Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Microbiome Therapeutics Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES MICROBIOME THERAPEUTICS MARKET SIZE (VALUE AND VOLUME) FORECAST (2018-2025)

11.1 United States Microbiome Therapeutics Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Microbiome Therapeutics Sales Volume Forecast by Type (2018-2025)
11.3 United States Microbiome Therapeutics Sales Volume Forecast by Application (2018-2025)
11.4 United States Microbiome Therapeutics Sales Volume Forecast by Region (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Microbiome Therapeutics
Figure United States Microbiome Therapeutics Market Size (K Units) by Type (2013-2025)
Figure United States Microbiome Therapeutics Sales Volume Market Share by Type (Product Category) in 2017
Figure Probiotic Type Product Picture
Figure Fructo-Oligosaccharides Product Picture
Figure Galacto-Oligosaccharides Product Picture
Figure Inulin Product Picture
Figure United States Microbiome Therapeutics Market Size (K Units) by Application (2013-2025)
Figure United States Sales Market Share of Microbiome Therapeutics by Application in 2017
Figure C. difficile Infection (CDI) Examples
Table Key Downstream Customer in C. difficile Infection (CDI)
Figure Inflammatory Bowel Disease (IBD) Examples
Table Key Downstream Customer in Inflammatory Bowel Disease (IBD)
Figure Orphan Drug Examples
Table Key Downstream Customer in Orphan Drug
Figure Immuno-oncology Examples
Table Key Downstream Customer in Immuno-oncology
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Microbiome Therapeutics Market Size (Million USD) by Region (2013-2025)
Figure The West Microbiome Therapeutics Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Microbiome Therapeutics Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Microbiome Therapeutics Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Microbiome Therapeutics Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Microbiome Therapeutics Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Microbiome Therapeutics Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Microbiome Therapeutics Sales (K Units) and Growth Rate (2013-2025)
Figure United States Microbiome Therapeutics Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Microbiome Therapeutics Market Major Players Product Sales Volume (K Units) (2013-2018)
Table United States Microbiome Therapeutics Sales (K Units) of Key Players/Suppliers (2013-2018)
Table United States Microbiome Therapeutics Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Microbiome Therapeutics Sales Share by Players/Suppliers
Figure 2017 United States Microbiome Therapeutics Sales Share by Players/Suppliers
Figure United States Microbiome Therapeutics Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Microbiome Therapeutics Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Microbiome Therapeutics Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Microbiome Therapeutics Revenue Share by Players/Suppliers
Figure 2017 United States Microbiome Therapeutics Revenue Share by Players/Suppliers
Table United States Market Microbiome Therapeutics Average Price (USD/Unit) of Key Players/Suppliers (2013-2018)
Figure United States Market Microbiome Therapeutics Average Price (USD/Unit) of Key Players/Suppliers in 2017
Figure United States Microbiome Therapeutics Market Share of Top 3 Players/Suppliers
Figure United States Microbiome Therapeutics Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Microbiome Therapeutics Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Microbiome Therapeutics Product Category
Table United States Microbiome Therapeutics Sales (K Units) by Region (2013-2018)
Table United States Microbiome Therapeutics Sales Share by Region (2013-2018)
Figure United States Microbiome Therapeutics Sales Share by Region (2013-2018)
Figure United States Microbiome Therapeutics Sales Market Share by Region in 2017
Table United States Microbiome Therapeutics Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Microbiome Therapeutics Revenue Share by Region (2013-2018)
Figure United States Microbiome Therapeutics Revenue Market Share by Region (2013-2018)
Figure United States Microbiome Therapeutics Revenue Market Share by Region in 2017
Table United States Microbiome Therapeutics Price (USD/Unit) by Region (2013-2018)
Table United States Microbiome Therapeutics Sales (K Units) by Type (2013-2018)
Table United States Microbiome Therapeutics Sales Share by Type (2013-2018)
Figure United States Microbiome Therapeutics Sales Share by Type (2013-2018)
Figure United States Microbiome Therapeutics Sales Market Share by Type in 2017
Table United States Microbiome Therapeutics Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Microbiome Therapeutics Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Microbiome Therapeutics by Type (2013-2018)
Figure Revenue Market Share of Microbiome Therapeutics by Type in 2017
Table United States Microbiome Therapeutics Price (USD/Unit) by Types (2013-2018)
Figure United States Microbiome Therapeutics Sales Growth Rate by Type (2013-2018)
Table United States Microbiome Therapeutics Sales (K Units) by Application (2013-2018)
Table United States Microbiome Therapeutics Sales Market Share by Application (2013-2018)
Figure United States Microbiome Therapeutics Sales Market Share by Application (2013-2018)
Figure United States Microbiome Therapeutics Sales Market Share by Application in 2017
Table United States Microbiome Therapeutics Sales Growth Rate by Application (2013-2018)
Figure United States Microbiome Therapeutics Sales Growth Rate by Application (2013-2018)
Table Seres Therapeutics Basic Information List
Table Seres Therapeutics Microbiome Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Seres Therapeutics Microbiome Therapeutics Sales Growth Rate (2013-2018)
Figure Seres Therapeutics Microbiome Therapeutics Sales Market Share in United States (2013-2018)
Figure Seres Therapeutics Microbiome Therapeutics Revenue Market Share in United States (2013-2018)
Table Assembly Biosciences Basic Information List
Table Assembly Biosciences Microbiome Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Assembly Biosciences Microbiome Therapeutics Sales Growth Rate (2013-2018)
Figure Assembly Biosciences Microbiome Therapeutics Sales Market Share in United States (2013-2018)
Figure Assembly Biosciences Microbiome Therapeutics Revenue Market Share in United States (2013-2018)
Table Synthetic Biologics Basic Information List
Table Synthetic Biologics Microbiome Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Synthetic Biologics Microbiome Therapeutics Sales Growth Rate (2013-2018)
Figure Synthetic Biologics Microbiome Therapeutics Sales Market Share in United States (2013-2018)
Figure Synthetic Biologics Microbiome Therapeutics Revenue Market Share in United States (2013-2018)
Table Interxon Basic Information List
Table Interxon Microbiome Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Interxon Microbiome Therapeutics Sales Growth Rate (2013-2018)
Figure Interxon Microbiome Therapeutics Sales Market Share in United States (2013-2018)
Figure Interxon Microbiome Therapeutics Revenue Market Share in United States (2013-2018)
Table PureTech Basic Information List
Table PureTech Microbiome Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure PureTech Microbiome Therapeutics Sales Growth Rate (2013-2018)
Figure PureTech Microbiome Therapeutics Sales Market Share in United States (2013-2018)
Figure PureTech Microbiome Therapeutics Revenue Market Share in United States (2013-2018)
Table Synlogic Basic Information List
Table Synlogic Microbiome Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Synlogic Microbiome Therapeutics Sales Growth Rate (2013-2018)
Figure Synlogic Microbiome Therapeutics Sales Market Share in United States (2013-2018)
Figure Synlogic Microbiome Therapeutics Revenue Market Share in United States (2013-2018)
Table Enterome BioScience Basic Information List
Table Enterome BioScience Microbiome Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Enterome BioScience Microbiome Therapeutics Sales Growth Rate (2013-2018)
Figure Enterome BioScience Microbiome Therapeutics Sales Market Share in United States (2013-2018)
Figure Enterome BioScience Microbiome Therapeutics Revenue Market Share in United States (2013-2018)
Table 4D Pharma Basic Information List
Table 4D Pharma Microbiome Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure 4D Pharma Microbiome Therapeutics Sales Growth Rate (2013-2018)
Figure 4D Pharma Microbiome Therapeutics Sales Market Share in United States (2013-2018)
Figure 4D Pharma Microbiome Therapeutics Revenue Market Share in United States (2013-2018)
Table Second Genome Basic Information List
Table Second Genome Microbiome Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Second Genome Microbiome Therapeutics Sales Growth Rate (2013-2018)
Figure Second Genome Microbiome Therapeutics Sales Market Share in United States (2013-2018)
Figure Second Genome Microbiome Therapeutics Revenue Market Share in United States (2013-2018)
Table AOBiome Basic Information List
Table AOBiome Microbiome Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure AOBiome Microbiome Therapeutics Sales Growth Rate (2013-2018)
Figure AOBiome Microbiome Therapeutics Sales Market Share in United States (2013-2018)
Figure AOBiome Microbiome Therapeutics Revenue Market Share in United States (2013-2018)
Table C3 Jian Basic Information List
Table Rebiotix Basic Information List
Table MicroBiome Therapeutics LLC Basic Information List
Table Metabiomics Basic Information List
Table Ritter Pharmaceuticals Basic Information List
Table Symberix Basic Information List
Table OpenBiome Basic Information List
Table Azitra Basic Information List
Table Symbiotix Biotherapies Basic Information List
Table Osel Basic Information List
Table Metabogen Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Microbiome Therapeutics
Figure Manufacturing Process Analysis of Microbiome Therapeutics
Figure Microbiome Therapeutics Industrial Chain Analysis
Table Raw Materials Sources of Microbiome Therapeutics Major Players/Suppliers in 2017
Table Major Buyers of Microbiome Therapeutics
Table Distributors/Traders List
Figure United States Microbiome Therapeutics Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure United States Microbiome Therapeutics Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Microbiome Therapeutics Price (USD/Unit) Trend Forecast (2018-2025)
Table United States Microbiome Therapeutics Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Microbiome Therapeutics Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Microbiome Therapeutics Sales Volume (K Units) Forecast by Type in 2025
Table United States Microbiome Therapeutics Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Microbiome Therapeutics Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Microbiome Therapeutics Sales Volume (K Units) Forecast by Application in 2025
Table United States Microbiome Therapeutics Sales Volume (K Units) Forecast by Region (2018-2025)
Table United States Microbiome Therapeutics Sales Volume Share Forecast by Region (2018-2025)
Figure United States Microbiome Therapeutics Sales Volume Share Forecast by Region (2018-2025)
Figure United States Microbiome Therapeutics Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources